Nanobac to study origin of gallstones

By Elaine Rigoli

Tampa, Fla., Aug. 23 - Nanobac Pharmaceuticals, Inc. has entered into an agreement and started work on an animal model to validate a proof of concept that calcifying nanoparticles, also known as nanobacteria, promote gallstones.

The company said that, if the proof is validated, it will solve the mystery of what provokes black pigment gallstones affecting millions of people, and forge a path to effective early diagnosis and therapy.

Results are expected by year-end 2006.

Because these gallstones contain material similar to that in kidney stones and breast cancer calcifications, the results could apply to other unsolved calcification-related conditions as well, the company noted.

Nanobac is a life-sciences company located in Tampa, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.